Without global action, drug-resistant infections will cause 10m deaths a year worldwide by 2050 and cost at least $100tn during the next 35 years, according to the first economic analysis of the problem. Clive Cookson, FT Science Editor, spoke to Jim O'Neill, former Goldman Sachs economist and author of the review, about its findings.

iTunes Stitcher audioBoom SoundCloud Overcast RSS


Copyright The Financial Times Limited 2017. All rights reserved.
myFT

Follow the topics related to this show

Comments have not been enabled for this podcast.